These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16002756)

  • 1. "Clinical-CT mismatch" and the response to systemic thrombolytic therapy in acute ischemic stroke.
    Kent DM; Hill MD; Ruthazer R; Coutts SB; Demchuk AM; Dzialowski I; Wunderlich O; von Kummer R
    Stroke; 2005 Aug; 36(8):1695-9. PubMed ID: 16002756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-CT mismatch defined NIHSS ≥ 8 and CT-ASPECTS ≥ 9 as a reliable marker of candidacy for intravenous thrombolytic therapy in acute ischemic stroke.
    Wu HM; Lee IH; Luo CB; Chung CP; Lin YY
    PLoS One; 2021; 16(4):e0251077. PubMed ID: 33930103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study.
    Demchuk AM; Hill MD; Barber PA; Silver B; Patel SC; Levine SR;
    Stroke; 2005 Oct; 36(10):2110-5. PubMed ID: 16166579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT-NIHSS mismatch does not correlate with MRI diffusion-perfusion mismatch.
    Messé SR; Kasner SE; Chalela JA; Cucchiara B; Demchuk AM; Hill MD; Warach S
    Stroke; 2007 Jul; 38(7):2079-84. PubMed ID: 17540971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke.
    Kharitonova T; Mikulik R; Roine RO; Soinne L; Ahmed N; Wahlgren N;
    Stroke; 2011 Jun; 42(6):1638-43. PubMed ID: 21512176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials.
    Warach S; Al-Rawi Y; Furlan AJ; Fiebach JB; Wintermark M; Lindstén A; Smyej J; Bharucha DB; Pedraza S; Rowley HA
    Stroke; 2012 Sep; 43(9):2313-8. PubMed ID: 22738918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study.
    Berlet MH; Stambo GW; Kelley M; Van Epps K; Woeste T; Steffen D
    J Stroke Cerebrovasc Dis; 2014; 23(5):869-78. PubMed ID: 24011839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CT angiography in thrombolysis decision-making for patients with presumed seizure at stroke onset.
    Sylaja PN; Dzialowski I; Krol A; Roy J; Federico P; Demchuk AM;
    Stroke; 2006 Mar; 37(3):915-7. PubMed ID: 16456124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke scale items associated with neurologic deterioration within 24 hours after recombinant tissue plasminogen activator therapy.
    Nanri Y; Yakushiji Y; Hara M; Eriguchi M; Okada R; Yukitake M; Hara H
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1117-24. PubMed ID: 23199533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of severity of stroke and aphasia recovery early after intravenous recombinant tissue plasminogen activator thrombolysis.
    Kremer C; Kappelin J; Perren F
    J Clin Neurosci; 2014 Oct; 21(10):1828-30. PubMed ID: 24852905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal outcome measures for detecting clinical benefits of early reperfusion: insights from the DEFUSE Study.
    Kakuda W; Hamilton S; Thijs VN; Lansberg MG; Kemp S; Skalabrin E; Albers GW;
    J Stroke Cerebrovasc Dis; 2008; 17(4):235-40. PubMed ID: 18589345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining acute diffusion-weighted imaging and mean transmit time lesion volumes with National Institutes of Health Stroke Scale Score improves the prediction of acute stroke outcome.
    Yoo AJ; Barak ER; Copen WA; Kamalian S; Gharai LR; Pervez MA; Schwamm LH; González RG; Schaefer PW
    Stroke; 2010 Aug; 41(8):1728-35. PubMed ID: 20595665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.